These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

877 related items for PubMed ID: 14560344

  • 41. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion.
    Kang JH, Lee DI, Kim S, Kim MN, Park YM, Ban JE, Choi JI, Lim HE, Park SW, Kim YH.
    J Cardiovasc Electrophysiol; 2012 Nov; 23(11):1165-70. PubMed ID: 22882453
    [Abstract] [Full Text] [Related]

  • 42. A decrease in serum aldosterone level is associated with maintenance of sinus rhythm after successful cardioversion of atrial fibrillation.
    Wozakowska-Kaplon B, Bartkowiak R, Janiszewska G.
    Pacing Clin Electrophysiol; 2010 May; 33(5):561-5. PubMed ID: 20059712
    [Abstract] [Full Text] [Related]

  • 43. [Elective electric cardioversion of atrial fibrillation in adults with underlying heart disease: a proposal of optimizing the procedure].
    Sermasi S, Marconi M, Cioppi F.
    G Ital Cardiol; 1995 Nov; 25(11):1399-406. PubMed ID: 8682235
    [Abstract] [Full Text] [Related]

  • 44. The implementation of a comprehensive clinical protocol improves long-term success after surgical treatment of atrial fibrillation.
    Ad N, Henry L, Hunt S, Stone L.
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1146-52. PubMed ID: 20412955
    [Abstract] [Full Text] [Related]

  • 45. Restoring sinus rhythm results in blood pressure reduction in patients with persistent atrial fibrillation and a history of hypertension.
    Sanders NA, Bertolone C, Jetter TL, Wasmund SL, Croci F, Solano A, Brignole M, Hamdan MH.
    J Cardiovasc Electrophysiol; 2012 Jul; 23(7):722-6. PubMed ID: 22494504
    [Abstract] [Full Text] [Related]

  • 46. Identification of good responders to rhythm control of paroxysmal and persistent atrial fibrillation by transthoracic and transesophageal echocardiography.
    Wang YC, Lin LC, Lin MS, Lai LP, Hwang JJ, Tseng YZ, Tseng CD, Lin JL.
    Cardiology; 2005 Jul; 104(4):202-9. PubMed ID: 16155395
    [Abstract] [Full Text] [Related]

  • 47. Correlation between inflammation state and successful medical cardioversion using bepridil for refractory atrial fibrillation.
    Nishino M, Mori N, Nakamura D, Lee Y, Yoshimura T, Taniike M, Makino N, Kato H, Egami Y, Shutta R, Tanouchi J, Yamada Y.
    J Cardiol; 2013 Aug; 62(2):117-20. PubMed ID: 23623817
    [Abstract] [Full Text] [Related]

  • 48. Improving outcomes in patients with atrial fibrillation: rationale and design of the Early treatment of Atrial fibrillation for Stroke prevention Trial.
    Kirchhof P, Breithardt G, Camm AJ, Crijns HJ, Kuck KH, Vardas P, Wegscheider K.
    Am Heart J; 2013 Sep; 166(3):442-8. PubMed ID: 24016492
    [Abstract] [Full Text] [Related]

  • 49. Guidelines' criteria for rate control in atrial fibrillation: are they useful?
    Ariansen I, Abdelnoor M, Tveit A, Gjesdal K.
    Scand Cardiovasc J; 2010 Jun; 44(3):132-8. PubMed ID: 20184511
    [Abstract] [Full Text] [Related]

  • 50. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
    Pisters R, Nieuwlaat R, Prins MH, Le Heuzey JY, Maggioni AP, Camm AJ, Crijns HJ, Euro Heart Survey Investigators.
    Europace; 2012 May; 14(5):666-74. PubMed ID: 22223715
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Increased plasma aldosterone during atrial fibrillation declines following cardioversion.
    Soeby-Land C, Dixen U, Therkelsen SK, Kjaer A.
    Cardiology; 2011 May; 118(4):239-44. PubMed ID: 21734375
    [Abstract] [Full Text] [Related]

  • 54. The influence of atrial fibrillation on prognosis in mild to moderate heart failure. The V-HeFT Studies. The V-HeFT VA Cooperative Studies Group.
    Carson PE, Johnson GR, Dunkman WB, Fletcher RD, Farrell L, Cohn JN.
    Circulation; 1993 Jun; 87(6 Suppl):VI102-10. PubMed ID: 8500233
    [Abstract] [Full Text] [Related]

  • 55. [Role amiodarone in sinus rhythm maintenance after successful cardioversion in patients with chronic non-valvular atrial fibrillation].
    Kosior D, Szulc M, Zawadzka M, Pierścińska M, Stawicki S, Rabczenko D, Torbicki A, Opolski G.
    Pol Arch Med Wewn; 2002 Dec; 108(6):1151-60. PubMed ID: 12687927
    [Abstract] [Full Text] [Related]

  • 56. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation.
    Rajagopalan B, Curtis AB.
    Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136
    [Abstract] [Full Text] [Related]

  • 57. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: management of recent-onset atrial fibrillation and flutter in the emergency department.
    Stiell IG, Macle L, CCS Atrial Fibrillation Guidelines Committee.
    Can J Cardiol; 2011 Nov; 27(1):38-46. PubMed ID: 21329861
    [Abstract] [Full Text] [Related]

  • 58. Clinical predictors of atrial fibrillation recurrence in the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico-Atrial Fibrillation (GISSI-AF) trial.
    Disertori M, Lombardi F, Barlera S, Latini R, Maggioni AP, Zeni P, Di Pasquale G, Cosmi F, Franzosi MG, GISSI-AF Investigators.
    Am Heart J; 2010 May; 159(5):857-63. PubMed ID: 20435196
    [Abstract] [Full Text] [Related]

  • 59. The RecordAF study: design, baseline data, and profile of patients according to chosen treatment strategy for atrial fibrillation.
    Le Heuzey JY, Breithardt G, Camm J, Crijns H, Dorian P, Kowey PR, Merioua I, Prystowsky EN, Schwartz PJ, Torp-Pedersen C, Weintraub W.
    Am J Cardiol; 2010 Mar 01; 105(5):687-93. PubMed ID: 20185018
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 44.